(Q41380460)

30 September 2017

1 reference

title

Tamoxifen and secondary tumours. An update (English)

1 reference

30 September 2017

1 reference

N Wilking

1

1 reference

30 September 2017

E Isaksson

series ordinal

2

1 reference

30 September 2017

E von Schoultz

series ordinal

3

1 reference

30 September 2017

publication date

1 February 1997

1 reference

30 September 2017

1 reference

30 September 2017

volume

16

1 reference

30 September 2017

issue

2

1 reference

30 September 2017

page(s)

104-117

1 reference

Endometriosis developing during tamoxifen therapy

30 September 2017

cites work

1 reference

12 December 2020

Endocrine effects of tamoxifen in postmenopausal breast cancer patients

1 reference

12 December 2020

The pharmacology and clinical uses of tamoxifen

1 reference

12 December 2020

Should clinicians be concerned about the carcinogenic potential of tamoxifen?

1 reference

12 December 2020

Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats

1 reference

12 December 2020

Tamoxifen: disease prevention or disease substitution?

1 reference

12 December 2020

Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen

1 reference

12 December 2020

Studies on the mechanism of action of the nonsteroidal antioestrogen tamoxifen (I.C.I. 46,474) in the rat.

1 reference

12 December 2020

Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats

1 reference

12 December 2020

Incidence of New Primary Cancers After Adjuvant Tamoxifen Therapy and Radiotherapy for Early Breast Cancer

1 reference

12 December 2020

Leiomyomas in patients receiving Tamoxifen

1 reference

12 December 2020

Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group

1 reference

12 December 2020

Discovering the truth about tamoxifen: problems of multiplicity in statistical evaluation of biomedical data.

1 reference

12 December 2020

Adjuvant therapy of breast cancer: compliance and data validity in a multicenter trial

1 reference

12 December 2020

Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen

1 reference

12 December 2020

Cytochrome P-450-mediated activation and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver: possible involvement of flavin-containing monooxygenases in tamoxifen activation

1 reference

12 December 2020

The value of progesterone receptor assays in the management of advanced breast cancer

1 reference

12 December 2020

Rapid induction of the c-jun protooncogene in the avian oviduct by the antiestrogen tamoxifen

1 reference

12 December 2020

A mechanistic hypothesis for DNA adduct formation by tamoxifen following hepatic oxidative metabolism.

1 reference

12 December 2020

Role of prolonged stimulation of tamoxifen therapy in the etiology of endometrial sarcomas

1 reference

12 December 2020

Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells

1 reference

12 December 2020

Oestrogen receptors and metabolism of oestrone sulphate in human mammary carcinoma

1 reference

12 December 2020

Lack of induction of endometrial hyperplasia with tamoxifen

1 reference

12 December 2020

Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy

1 reference

12 December 2020

Antiestrogens in the treatment of breast cancer

1 reference

12 December 2020

A case-control study of large bowel cancer and hormone exposure in women

1 reference

12 December 2020

Tamoxifen induces hepatocellular carcinoma in rat liver: a 1-year study with two antiestrogens

1 reference

12 December 2020

Mechanisms of action of endocrine treatment in breast cancer

1 reference

12 December 2020

In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway

1 reference

12 December 2020

Microsomal and peroxidase activation of 4-hydroxy-tamoxifen to form DNA adducts: comparison with DNA adducts formed in Sprague-Dawley rats treated with tamoxifen.

1 reference

12 December 2020

Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee

1 reference

12 December 2020

Endometrial cancer. Management of high risk and recurrence including the tamoxifen controversy

1 reference

12 December 2020

Alterations of drug metabolizing and antioxidant enzyme activities during tamoxifen-induced hepatocarcinogenesis in the rat.

1 reference

12 December 2020

Gynecologic effects of tamoxifen and the association with endometrial carcinoma

1 reference

12 December 2020

Tamoxifen and endometrial cancer

1 reference

12 December 2020

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer

1 reference

12 December 2020

A Retrospective Study of Tamoxifen and Endometrial Cancer in Breast Cancer Patients

1 reference

12 December 2020

Adenomyosis in postmenopausal breast cancer patients treated with tamoxifen: a new entity?

1 reference

12 December 2020

Endometrial lesions in patients undergoing tamoxifen therapy

1 reference

12 December 2020

Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers

1 reference

12 December 2020

Evidence for the hormone dependency of hepatic hyperplastic nodules: inhibition of malignant transformation after exogenous 17 beta-estradiol and tamoxifen.

1 reference

12 December 2020

Tamoxifen induced adenomyosis and adenomyomatous endometrial polyp

1 reference

12 December 2020

Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme

1 reference

12 December 2020

Postmenopausal tamoxifen treatment and endometrial pathology

1 reference

12 December 2020

[Post-menopausal endometriosis developed during tamoxifen treatment]

1 reference

12 December 2020

Project of experimental bioassays on chemoprevention agents performed at the Bologna Institute of Oncology: report on tamoxifen control of spontaneous mammary tumors on Sprague-Dawley rats

1 reference

12 December 2020

Tamoxifen and the uterus and endometrium

1 reference

12 December 2020

Tamoxifen and tumorigenicity: a predictable concern

1 reference

12 December 2020

The cytochromes P-448--a unique family of enzymes involved in chemical toxicity and carcinogenesis

1 reference

12 December 2020

Inhibitory effect of tamoxifen on diethylstilbestrol-promoted hepatic tumorigenesis in male rats and its possible mechanism of action

1 reference

12 December 2020

Hormonal manipulation and gynaecological cancer: the tamoxifen dilemma.

1 reference

12 December 2020

A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity

1 reference

12 December 2020

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Adjuvant randomized trials of doxorubicin/cyclophosphamide versus doxorubicin/cyclophosphamide/tamoxifen and CMF chemotherapy versus tamoxifen in women with node-positive breast cancer

1 reference

12 December 2020

Risk of endometrial cancer after tamoxifen treatment of breast cancer

1 reference

12 December 2020

Tamoxifen and the uterus

1 reference

12 December 2020

Hysteroscopic follow-up during tamoxifen treatment

1 reference

12 December 2020

Tamoxifen for breast cancer prevention

1 reference

12 December 2020

Second cancer following cancer of the breast in Connecticut, 1935-82

1 reference

12 December 2020

False sonographic appearance of endometrial neoplasia in postmenopausal women treated with tamoxifen

1 reference

12 December 2020

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

1 reference

12 December 2020

32P-postlabelled DNA adducts in liver obtained from women treated with tamoxifen

1 reference

12 December 2020

The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women. Clinical correlation on 547 patients

1 reference

12 December 2020

Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium

1 reference

12 December 2020

Effect of tamoxifen and tamoxifen derivatives on the conversion of estrone-sulfate to estradiol in the R-27 cells, a tamoxifen-resistant line derived from MCF-7 human breast cancer cells

1 reference

12 December 2020

Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients

1 reference

12 December 2020

Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features

1 reference

12 December 2020

Role of estrogens as promoters of hepatic neoplasia

1 reference

12 December 2020

Tamoxifen and the uterus and endometrium

1 reference

12 December 2020

Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group

1 reference

12 December 2020

The influence of exogenous estrogen use on survival after diagnosis of endometrial cancer

1 reference

12 December 2020

Action of "pure" antiestrogens in inhibiting estrogen receptor action

1 reference

12 December 2020

Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite.

1 reference

12 December 2020

Calcium antagonism by the antioestrogen tamoxifen

1 reference

12 December 2020

Endocrine pharmacology of antiestrogens as antitumor agents

1 reference

12 December 2020

Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer

1 reference

12 December 2020

Adjuvant treatment of postmenopausal patients with high risk primary breast cancer. Results from the Danish adjuvant trials DBCG 77 C and DBCG 82 C.

1 reference

12 December 2020

Exogenous hormones in the aetiology of cancer in women

1 reference

12 December 2020

The Christie hospital adjuvant tamoxifen trial--status at 10 years

1 reference

12 December 2020

Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens

1 reference

12 December 2020

Effects of tamoxifen on cardiovascular risk factors in postmenopausal women

1 reference

12 December 2020

Tamoxifen and endometrial cancer

1 reference

12 December 2020

Tamoxifen increases plasma estrogen-binding equivalents and has an estradiol agonistic effect on histologically normal premenopausal and postmenopausal endometrium

1 reference

12 December 2020

A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic

1 reference

12 December 2020

Endometrial polyps in postmenopausal patients receiving tamoxifen

1 reference

12 December 2020

Gynaecological monitoring during tamoxifen therapy

1 reference

12 December 2020

Tamoxifen-induced generalized lipidosis in rats subchronically treated with high doses

1 reference

12 December 2020

Tamoxifen and the uterus and endometrium

1 reference

12 December 2020

Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use.

1 reference

12 December 2020

Results of the Cancer Research Campaign Adjuvant Trial for Perioperative Cyclophosphamide and Long-Term Tamoxifen in Early Breast Cancer reported at the tenth year of follow-up. Cancer Research Campaign Breast Cancer Trials Group

1 reference

12 December 2020

Effect of tamoxifen on endometrial proliferation

1 reference

12 December 2020

The Stockholm trial on adjuvant tamoxifen in early breast cancer. Correlation between estrogen receptor level and treatment effect

1 reference

12 December 2020

The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat.

1 reference

12 December 2020

Steroid receptors in human breast cancer

1 reference

12 December 2020

Changes in estrogen receptor, DNA ploidy, and estrogen metabolism in rat hepatocytes during a two-stage model for hepatocarcinogenesis using 17 alpha-ethinylestradiol as the promoting agent

1 reference

12 December 2020

Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen

1 reference

12 December 2020

DNA adduct formation by tamoxifen with rat and human liver microsomal activation systems

1 reference

12 December 2020

Pathology of endometrium treated with tamoxifen

1 reference

12 December 2020

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

12 December 2020

Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. CRC Adjuvant Breast Trial Working Party

1 reference

12 December 2020

The effect of estradiol-17-phenylpropionate and estradiol benzoate on N-nitrosomorpholine-induced liver carcinogenesis in ovariectomized female rats

1 reference

12 December 2020

Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats

1 reference

12 December 2020

Epidemiologic data on exogenous hormones and hepatocellular carcinoma and selected other cancers

1 reference

12 December 2020

Second cancer following cancer of the female breast in Denmark, 1943-80.

1 reference

12 December 2020

Multiple cancer--an epidemiologic exercise in Finland

1 reference

12 December 2020

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

12 December 2020

Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding

1 reference

12 December 2020

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

1 reference

12 December 2020

Induction of covalent DNA adducts in rodents by tamoxifen.

1 reference

12 December 2020

The incidence of hepatocellular carcinoma in US white women with breast cancer after the introduction of tamoxifen in 1977

1 reference

12 December 2020

Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial

1 reference

12 December 2020

Activation of the tamoxifen derivative metabolite E to form DNA adducts: comparison with the adducts formed by microsomal activation of tamoxifen

1 reference

12 December 2020

Uterine malignant mixed müllerian tumor in a patient on long-term tamoxifen therapy for breast cancer

1 reference

12 December 2020

Common endometrial decidual reaction in postmenopausal breast cancer patients treated with tamoxifen and progestogens.

1 reference

12 December 2020

Quantitative predictability of carcinogenicity of the covalent binding index of chemicals to DNA: comparison of the in vivo and in vitro assays

1 reference

12 December 2020

Tamoxifen therapy and carcinogenic risk.

1 reference

12 December 2020

Regression of liver cell adenomas associated with oral contraceptives

1 reference

12 December 2020

The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function

1 reference

12 December 2020

Structural requirements for the in vitro transformation of Syrian hamster embryo cells by stilbene estrogens and triphenylethylene-type antiestrogens.

1 reference

12 December 2020

Tamoxifen in advanced breast cancer

1 reference

12 December 2020

Endometrial decidual changes in a postmenopausal woman treated with tamoxifen and megestrol acetate

1 reference

12 December 2020

Reproductive factors, exogenous female hormones, and colorectal cancer by subsite

1 reference

12 December 2020

Frequent and specific mutations of the rat p53 gene in hepatocarcinomas induced by tamoxifen

1 reference

12 December 2020

Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: the effects of tamoxifen

1 reference

12 December 2020

Endometrial thickness as measured by endovaginal ultrasonography for identifying endometrial abnormality

1 reference

12 December 2020

Cellular biochemistry of the stepwise development of cancer with chemicals: G. H. A. Clowes memorial lecture.

1 reference

12 December 2020

Biochemical pharmacology of antiestrogen action

1 reference

12 December 2020

Use of intracavity saline instillation and transvaginal ultrasonography to detect tamoxifen-associated endometrial polyps

1 reference

12 December 2020

Tamoxifen induces short-term cumulative DNA damage and liver tumors in rats: promotion by phenobarbital.

1 reference

12 December 2020

Uterine mullerian adenosarcoma following adenomyoma in a woman on tamoxifen therapy

1 reference

12 December 2020

Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues.

1 reference

12 December 2020

Down-regulation of transforming growth factor-alpha by tamoxifen in human breast cancer

1 reference

12 December 2020

Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of the literature

1 reference

12 December 2020

Gynaecological monitoring during tamoxifen therapy

1 reference

12 December 2020

10.2165/00002018-199716020-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

30 September 2017

1020810677

0 references

1 reference